Page last updated: 2024-09-05

ly 300164 and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

ly 300164 has been researched along with 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline in 6 studies

Compound Research Comparison

Studies
(ly 300164)
Trials
(ly 300164)
Recent Studies (post-2010)
(ly 300164)
Studies
(2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline)
Trials
(2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline)
Recent Studies (post-2010) (2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline)
737121,2160229

Protein Interaction Comparison

ProteinTaxonomyly 300164 (IC50)2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline (IC50)
Glutamate receptor 1Rattus norvegicus (Norway rat)0.5781
Glutamate receptor 2Rattus norvegicus (Norway rat)0.5781
Glutamate receptor 3Rattus norvegicus (Norway rat)0.5781
Glutamate receptor 4Rattus norvegicus (Norway rat)0.5781
Glutamate receptor ionotropic, kainate 1Rattus norvegicus (Norway rat)2.909
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, kainate 2Rattus norvegicus (Norway rat)2.909
Glutamate receptor 1Homo sapiens (human)6
Glutamate receptor 2Homo sapiens (human)2.5
Glutamate receptor 3Homo sapiens (human)1.9
Glutamate receptor ionotropic, kainate 3Rattus norvegicus (Norway rat)2.909
Glutamate receptor 4Homo sapiens (human)1.1
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, kainate 4Rattus norvegicus (Norway rat)2.909
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, kainate 5Rattus norvegicus (Norway rat)2.909
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)0.2

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cagnotto, A; Colleoni, S; Diana, V; Grasso, S; Lazzaro, J; Mennini, T; Micale, N; Pellicanò, A; Postorino, G; Zappalà, M1
Carcache, D; Kalkman, HO; Koller, M; Mattes, H1
Deverill, M; Hoo, KH; Iyengar, S; Li, DL; Ornstein, PL; Simmons, RM1
Jiang, L; Kang, J; Nedergaard, M; Xu, J1
Barkoczy, J; Gigler, G; Gressens, P; Harsing, LG; Kapus, G; Kertesz, S; Levay, G; Medja, F; Spedding, M; Szenasi, G; Villa, P; Williamson, T1
Aujla, PK; Fishman, R; Jensen, FE; Rakhade, SN; Sucher, NJ; Zhou, C1

Other Studies

6 other study(ies) available for ly 300164 and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

ArticleYear
Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino-3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent.
    Bioorganic & medicinal chemistry, 2008, Mar-01, Volume: 16, Issue:5

    Topics: Animals; Benzodiazepines; Benzodiazepinones; Calcium; Cells, Cultured; Hippocampus; Inhibitory Concentration 50; Kainic Acid; Ligands; Mice; Molecular Structure; Neurons; Neuroprotective Agents; Protein Binding; Receptors, AMPA; Structure-Activity Relationship

2008
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
    Journal of medicinal chemistry, 2010, Aug-12, Volume: 53, Issue:15

    Topics: Analgesics; Animals; Anticonvulsants; Antipsychotic Agents; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Neuroprotective Agents; Protein Subunits; Receptors, AMPA

2010
Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat.
    Neuropharmacology, 1998, Volume: 37, Issue:1

    Topics: Animals; Benzodiazepines; Excitatory Amino Acid Antagonists; Formaldehyde; Humans; Isoquinolines; Male; Pain Threshold; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Tetrazoles

1998
A kainate receptor increases the efficacy of GABAergic synapses.
    Neuron, 2001, Volume: 30, Issue:2

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzoates; Benzodiazepines; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Evoked Potentials; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Glycine; Hippocampus; In Vitro Techniques; Interneurons; Kainic Acid; Neurons; Protein Kinase C; Pyramidal Cells; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Staurosporine; Synapses; Tetradecanoylphorbol Acetate; Tetrodotoxin

2001
The effects of AMPA receptor antagonists in models of stroke and neurodegeneration.
    European journal of pharmacology, 2005, Sep-05, Volume: 519, Issue:1-2

    Topics: Animals; Animals, Newborn; Anticonvulsants; Benzodiazepines; Brain; Brain Ischemia; Cell Survival; Chickens; Cortical Spreading Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Excitatory Amino Acid Antagonists; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred Strains; Motor Neurons; Nerve Degeneration; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Retina; Seizures; Stroke

2005
Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Aug-06, Volume: 28, Issue:32

    Topics: Animals; Animals, Newborn; Anticonvulsants; Benzodiazepines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP-Dependent Protein Kinases; Disease Susceptibility; Enzyme Activation; Epilepsy; Excitatory Postsynaptic Potentials; Fructose; Hypoxia; Male; Phosphorylation; Protein Kinase C; Quinoxalines; Rats; Rats, Long-Evans; Receptors, AMPA; Synapses; Topiramate

2008